Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(12):73 Int J Neuropsychopharmacol. 2015 23-Feb;():. 10.1093/ijnp/pyv072Study Summary
Sixteen healthy subjects were included in this double-blind, placebo-controlled, cross-over study examining the single-dose kinetics and pharmacokinetic-pharmacodynamic relationships of oral lysergic acid diethylamide (LSD). Participants were given 200 μg LSD or placebo over 2 experimental test sessions with a washout period of at least 7 days between sessions. LSD and 2-oxo-3-hydroxy-lysergic acid diethylamide (O-H-LSD) concentrations in plasma and urine were determined using a validated liquid-chromatography-tandem mass-spectrometry, and drug effect was measured using the visual analogue scale. The acute subjective and sympathomimetic responses to lysergic acid diethylamide lasted up to 12 hours and were closely associated with the concentrations in plasma over time. Maximal concentrations of lysergic acid diethylamide were reached 1.5 (median, range 0.5-4) hours after administration. One percent of the orally administered LSD was eliminated in urine as LSD, and 13% was eliminated as O-H-LSD within 24 hours.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!